spine fusion
-
Biologics
Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
If approved, the breakthrough product will bring Cerapedics’ P-15 Peptide to lumbar spine fusion with a TLIF indication, making it…
Read More » -
Spine
Centinel Spine® Continues Drive to Number One Global Market Position in Total Disc Replacement through Divestment of its Spine Fusion Business to Silony Medical
The transaction includes the sale of all cervical and lumbar fusion products, including the STALIF® technology platform. Divestment of the fusion portfolio…
Read More » -
Spine
Augmedics Begins First-in-Human Clinical Trial of xvision-spine (XVS) Augmented-Reality Surgical Navigation System
August 08, 2018 YOKNEAM, Israel–(BUSINESS WIRE)–Augmedics has begun a first-in-human clinical trial of its xvision-spine (XVS) augmented-reality surgical navigation system at…
Read More » -
Spine
Centinel Spine™ is Granted the First Cervical Multilevel Indication for Its STALIF C® Integrated Interbody™ Device
NEW YORK, June 30, 2015 /PRNewswire/ — Centinel Spine, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody fusion devices was granted…
Read More » -
Spine
Adolescent Spinal Fusion: 5 Findings on VTE Complication
Written by Laura Dyrda A group of spine surgeon researchers examined trends for thromboembolic complications in children who underwent spinal fusion…
Read More » -
Sharp Rise in Use of Bone Growth Factor for Spinal Fusion Surgery
Bone Morphogenetic Protein Is Safe—But Increases Costs Without Improving Results Newswise — Philadelphia, Pa. (January 31, 2012) – The use…
Read More » -
Spine
Disc Replacement Tops Fusion in Study
Disc replacement or fusion—which is better? A study conducted at Cedars-Sinai Spine Center and reported by Laura Miller of Becker’s Orthopedics examined…
Read More » -
Medtronic Spinal Fusion Device Faces FDA Review of Safety, Effectiveness
Medtronic Inc.’s experimental spinal fusion device Amplify didn’t work as well after five years as it did in two-year tests…
Read More »